A2 reactive astrocyte‐derived exosomes alleviate cerebral ischemia–reperfusion injury by delivering miR ‐628
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Yingju Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People's Republic of China. Hauptthemen laut MEDLINE: MicroRNAs, Astrocytes, Reperfusion Injury, Exosomes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heilongjiang Province Key R&D Program.
Abstract (Originalsprache)
Ischemia and hypoxia activate astrocytes into reactive types A1 and A2, which play roles in damage and protection, respectively. However, the function and mechanism of A1 and A2 astrocyte exosomes are unknown. After astrocyte exosomes were injected into the lateral ventricle, infarct volume, damage to the blood–brain barrier (BBB), apoptosis and the expression of microglia‐related proteins were measured. The dual luciferase reporter assay was used to detect the target genes of miR‐628, and overexpressing A2‐Exos overexpressed and knocked down miR‐628 were constructed. qRT–PCR, western blotting and immunofluorescence staining were subsequently performed. A2‐Exos obviously reduced the infarct volume, damage to the BBB and apoptosis and promoted M2 microglial polarization. RT–PCR showed that miR‐628 was highly expressed in A2‐Exos. Dual luciferase reporter assays revealed that NLRP3, S1PR3 and IRF5 are target genes of miR‐628. After miR‐628 was overexpressed or knocked down, the protective effects of A2‐Exos increased or decreased, respectively. A2‐Exos reduced pyroptosis and BBB damage and promoted M2 microglial polarization through the inhibition of NLRP3, S1PR3 and IRF5 via the delivery of miR‐628. This study explored the mechanism of action of A2‐Exos and provided new therapeutic targets and concepts for treating cerebral ischemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People's Republic of China.
- Department of Emergency, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
- Department of Neurology, Heilongjiang Provincial Hospital, Harbin, Heilongjiang, People's Republic of China.
ORCID-Profile: Guozhong Li
Förderung
- Heilongjiang Province Key R&D Program
Zitieren
APA
Wang, Y., Li, H., Sun, H., Xu, C., Sun, H., Wei, W., Song, J., Jia, F., Zhong, D., & Li, G. (2024). A2 reactive astrocyte‐derived exosomes alleviate cerebral ischemia–reperfusion injury by delivering miR ‐628. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70004
Vancouver
Wang Y, Li H, Sun H, Xu C, Sun H, Wei W, et al. A2 reactive astrocyte‐derived exosomes alleviate cerebral ischemia–reperfusion injury by delivering miR ‐628. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70004
BibTeX
@article{Wang2024,
author = {Wang, Yingju and Li, He and Sun, Hanwen and Xu, Chen and Sun, Hongxue and Wei, Wan and Song, Jihe and Jia, Feihong and Zhong, Di and Li, Guozhong},
title = {A2 reactive astrocyte‐derived exosomes alleviate cerebral ischemia–reperfusion injury by delivering miR ‐628},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70004}
}
EUVIMED